ClinicalTrials.Veeva

Menu
T

Texas Retina Associates | Plano, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KSI-301
Aflibercept
OCS-01
Yutiq
Tarcocimab

Parent organization

This site is a part of Texas Retina Associates

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (...

Enrolling
Wet Age-related Macular Degeneration
Drug: Tarcocimab tedromer
Drug: Aflibercept

This study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with moderately severe to severe NPDR.

Enrolling
Non-proliferative Diabetic Retinopathy
Drug: Tarcocimab
Other: Sham injection

The goal of the LEOPARD clinical trial is to investigate a new kind of steroid eye drops, OCS-01.Macular edema is a condition in which there is colle...

Enrolling
Uveitis Related Cystoid Macular Edema
Cystoid Macular Edema, Postoperative
Drug: OCS-01

Trial sponsors

Kodiak Sciences logo
C
Q
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems